Home
About
Members & partners
Governance & financing
Get involved
Contact
Zero-dose
News & opportunities
Submit news & resources
Newsletter
Member profiles
Resources
Guidance, tools & data
Educational resources
Data repository
COVID-19 costing
Featured projects
Events
2025 IHEA Congress
World Vaccine Congress 2025: Europe
World Vaccine Congress 2025: Washington, DC
2023 IHEA
2022 Health Systems Research Symposium
2021 IHEA
2019 IHEA
2016 Immunization Costing Workshop
2017 Value of Vaccination Research Workshop
Home
Zero-dose
News & opportunities
News & opportunities
Submit news & resources
Newsletter sign up & archive
Member profiles
Resources
Resource library
Guidance, tools & data
Educational resources
COVID-19 costing
From key partners
DOVE
EPIC
IMFIN
ProVac
ThinkWell
TVEE
UNICEF
VERSE
VoVRN
Events
2025 IHEA
2025 World Vaccine Congress: Europe
2025 World Vaccine Congress: Washington, DC
2023 IHEA
2022 Health Systems Research Symposium
2021 IHEA
2019 IHEA
2017 Value of Vaccination Research Workshop
2016 Immunization Costing Workshop
About
About
Core partners
Members & partners
Governance & financing
Get involved
Contact
Donate
North America
Tag
Evaluating the cost-effectiveness of PCV20 for pneumococcal disease prevention
August 26, 2025
adult vaccination
,
cost-effectiveness
,
Mexico
,
North America
,
Peer reviewed article
,
Pfizer
,
Pneumococcal
,
Routine immunization
,
Study
,
Vaccine development
Read More
Opportunity: Technical Officer, Revolving Fund for Access to Vaccines at PAHO
January 3, 2025
English
,
Financing
,
Job opportunity
,
North America
,
PAHO
,
South America
,
Spanish
Read More
Study on the health-economic burden associated with novel serotypes in next generation pneumococcal conjugate vaccines
October 1, 2024
2024
,
Economic & social benefits
,
English
,
North America
,
Peer reviewed article
,
Pneumococcal
,
Study
,
United States
,
Vaccine development
,
Value of Vaccines
Read More
The Benefits and Costs of U.S. Employer COVID-19 Vaccine Mandates
January 24, 2024
2022
,
Covid-19
,
Economic & social benefits
,
English
,
Harvard T.H. Chan School of Public Health
,
Harvard University
,
North America
,
United States
,
Value of Vaccines
,
Working paper
Read More
Opening for a Research Associate in the Economics and Finance Team at the International Vaccine Access Center
January 19, 2024
2024
,
Costing
,
English
,
International Vaccine Access Center
,
Job opportunity
,
Johns Hopkins Bloomberg School of Public Health
,
Johns Hopkins University
,
North America
,
United States
Read More
Influenza vaccination is economically attractive for most age and risk groups as shown in new Vaccine publication
July 25, 2023
2023
,
Economic & social benefits
,
English
,
Influenza
,
North America
,
Peer reviewed article
,
Study
,
U.S. CDC
,
United States
,
University of Michigan
,
Value of Vaccines
Read More
Provider financial incentives for HPV vaccination: Pervasiveness and clinic staff eligibility
July 10, 2023
2023
,
Conference materials
,
Demand generation
,
English
,
HPV
,
IHEA 2023 congress
,
North America
,
Presentation
,
Study
,
United States
,
University of North Carolina
Read More
Guidelines for the economic evaluation of vaccination programs in Canada
July 8, 2023
2023
,
Canada
,
Conference materials
,
Costing
,
English
,
IHEA 2023 Pre-congress
,
North America
,
poster
,
University of Toronto
Read More
Estimates of the value of averting nonfatal COVID-19 cases
September 12, 2022
2022
,
Cost of disease
,
Covid-19
,
Economic & social benefits
,
English
,
Harvard T.H. Chan School of Public Health
,
Harvard University
,
North America
,
Peer reviewed article
,
Study
,
United States
,
Value of Vaccines
Read More
Valuing COVID-19 morbidity risk reductions
August 22, 2022
2022
,
Cost of disease
,
Covid-19
,
Economic & social benefits
,
English
,
Harvard T.H. Chan School of Public Health
,
Harvard University
,
North America
,
Peer reviewed article
,
Study
,
United States
,
Value of Vaccines
Read More
1
2
3
Loading Comments...
Write a Comment...
Email
Name
Website
